Table IV.
Descent range of PGE2 in PDA closed and PDA unclosed, oliguria and non-oliguria patients.
| Descent range of PGE2 after treatment (ng/l) | PDA closed group (n=64) | PDA unclosed group (n=23) | Z/t | P-value | Oliguria group (n=7) | Nonoliguric group (n=80) | Z/t | P-value |
|---|---|---|---|---|---|---|---|---|
| Plasmaa | 13.7 (7.3, 25.6) | 15.7 (9.1, 25.3) | Z=0.067 | 0.946 | 35.0 (26.3, 49.8) | 13.3 (6.7, 20.8) | Z=−3.326 | 0.001 |
| Urineb | 61.1±44.7 | 53.7±39.2 | t=0.708 | 0.481 | 135.0±38.0 | 52.5±37.0 | t= 5.649 | 0.000 |
a
Median (25th and 75th percentile).
b
Mean ± standard deviation. PGE2, prostaglandin E2; PDA, patent ductus arteriosus.